SCANORTO A/S: Financial statements 2018
CVR: 12687648
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
SCANORTO A/S (CVR 12687648) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 8,161,111 and a net result of DKK 1,111,930 compared with DKK 264,498 the year before. That is a decrease of 5% compared with the year before. Equity in the 2018 report amounted to DKK 5,233,540. The solvency ratio was 49.5%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 8,161,111
- Profit/Loss
- DKK 1,111,930
- Equity
- DKK 5,233,540
- Total Assets
- DKK 10,573,073
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 8.2 mio. | 1.1 mio. | 5.2 mio. | 10 |
| 2017 | - | 8.6 mio. | 264 t. | 4.1 mio. | 11 |
| 2015 | - | 11.7 mio. | -3.5 mio. | 2.6 mio. | 18 |
| 2014 | - | 13.9 mio. | 2.5 mio. | 8.1 mio. | 17 |
| 2013 | - | 14.7 mio. | 4 mio. | 7.6 mio. | 15 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
SCANORTO A/S has published its annual report for 2017. Gross profit came to DKK 8,586,717, and the net result was DKK 264,498.
As of March 20, 2018, Maria Luisa Caggiula has joined the board of directors of SCANORTO A/S.
As of March 20, 2018, Lasse Lager has left the board of directors of SCANORTO A/S.
As of March 20, 2018, Steven Schwarz is registered as adm. dir. of SCANORTO A/S.
As of March 20, 2018, Lasse Lager has stepped down as director of SCANORTO A/S.
About SCANORTO A/S
SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.